SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-001027
Filing Date
2023-02-08
Accepted
2023-02-08 16:26:45
Documents
77
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q pahc-20221231x10q.htm   iXBRL 10-Q 1896185
2 EX-31.1 pahc-20221231xex31d1.htm EX-31.1 8160
3 EX-31.2 pahc-20221231xex31d2.htm EX-31.2 8124
4 EX-32.1 pahc-20221231xex32d1.htm EX-32.1 3883
5 EX-32.2 pahc-20221231xex32d2.htm EX-32.2 4149
  Complete submission text file 0001558370-23-001027.txt   7599778

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20221231.xsd EX-101.SCH 40680
7 EX-101.CAL pahc-20221231_cal.xml EX-101.CAL 71231
8 EX-101.DEF pahc-20221231_def.xml EX-101.DEF 213327
9 EX-101.LAB pahc-20221231_lab.xml EX-101.LAB 331444
10 EX-101.PRE pahc-20221231_pre.xml EX-101.PRE 354700
71 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20221231x10q_htm.xml XML 1473905
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 23599432
SIC: 2834 Pharmaceutical Preparations